Edwards Lifesciences Corp...

NYSE: EW · Real-Time Price · USD
78.24
0.06 (0.08%)
At close: Aug 15, 2025, 3:42 PM

Edwards Lifesciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
331.5M 356.4M 385.6M 3.07B 365M 351M 369.7M 383.7M 305.5M 340.5M 398.4M 343.5M 406.4M 373.6M 335.3M 340.1M 489.5M 338.2M
Depreciation & Amortization
38.1M 36.6M 42.6M 34.5M 39.6M 38.5M 36.7M 36.9M 36.1M 35.2M 35.4M 35.4M 34.1M 34.7M 33M 33.6M 35.8M 32.4M
Stock-Based Compensation
37.5M 40.2M 50.8M 42.1M 43.9M 44.6M 30.5M 32.6M 37.4M 38.9M 27.9M 30.3M 36.2M 32.4M 24.2M 26.6M 30.3M 28.2M
Other Working Capital
-262.1M -3.5M -514.7M 647.6M -101.4M -245.4M -108.9M 55.8M -57.7M 98.9M -50.5M -69.9M 19.4M 61.6M 127.3M 18.9M 600K -12.9M
Other Non-Cash Items
45.7M 22M -44.9M -3.35B 9.9M 7.2M 7.2M 16.5M -21.1M 7.9M 11.8M 61.5M 7.9M 24.6M -18.1M 5.1M -106.1M 100K
Deferred Income Tax
-20.9M -24.3M -98.5M -123M -66.1M -35.8M -91.4M -46M -82.9M -51.8M -105.8M -46.3M -59.8M -42.6M -61.5M 3.9M 5.4M 10.8M
Change in Working Capital
-141.7M -150.7M -463.1M 683.6M -20.8M -459M -216.1M -12.2M -241.4M -56.6M -84.9M -114.5M -92.6M -129.4M 60.7M 122.6M 71.2M -109.2M
Operating Cash Flow
290.2M 280.4M -127.5M 351.8M 371.5M -53.5M 136.6M 411.5M 33.6M 314.1M 282.8M 309.9M 332.2M 293.3M 373.6M 531.9M 526.1M 300.5M
Capital Expenditures
-49.3M -56M -49.8M -31.9M -85.4M -85.3M -101.6M -55.3M -47.9M -61.5M -89.1M -59.9M -43.1M -72.7M -93.8M -60.7M -69.3M -106M
Cash Acquisitions
3M -3M -298.2M 3.16B n/a n/a 46M 55.3M 47.9M -141.2M n/a n/a n/a n/a -13.1M 60.7M 69.3M n/a
Purchase of Investments
-630.3M -647.3M -390.7M -528.4M -13.3M -13.4M -58.6M -9.6M -6.6M -30.7M -83M -345.4M -148.4M -202.1M -1.05B -413.5M -339.8M -77.4M
Sales Maturities Of Investments
594.1M 845.6M 268.1M 175.9M 247M 166.6M 137.4M 180.4M 134.1M 263.9M 273.5M 224M 359.6M 502M 197.1M 113.6M 81.7M 136.8M
Other Investing Acitivies
-89.6M -54M -101.5M -77.7M -23.5M -4.8M -9.1M -81.8M -57.3M -30M -6.7M -20.2M -38.5M 2.3M -1.8M -77.5M -71.4M -3.1M
Investing Cash Flow
-172.1M 85.3M -576.7M 2.7B 124.8M 63.1M 14.1M 89M 70.2M 500K 94.7M -201.5M 129.6M 229.5M -965.9M -377.4M -329.5M -49.7M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -100K n/a -100K n/a -100K -100K -1.2M -400K
Common Stock Repurchased
-5.5M -258.6M -100K -901M -158.1M -200K -448.4M -174.4M -7.5M -249.3M -866M -100.4M -355.1M -405.6M -96.5M -1.8M -111.9M -302.6M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1M -50M 100K -75.7M 61.5M 61.9M 35.2M 31.1M 59.6M 42.7M 27.7M 30.5M 47.1M 37.5M 34.6M 40.9M 54.1M 28.7M
Financial Cash Flow
52.7M -258M 28.6M -976.7M -96.6M 61.7M -413.2M -143.3M 52.1M -206.6M -838.4M -69.9M -308.1M -368.1M -62M 39M -59M -274.3M
Net Cash Flow
141.2M 90M -624.6M 2.04B 429.1M 81M -265.9M 366.4M 171.1M 103.8M -479.1M 48.8M 167.6M 167.9M -652.5M 194M 135M -9.3M
Free Cash Flow
240.9M 224.4M -177.3M 319.9M 286.1M -138.8M 35M 356.2M -14.3M 252.6M 193.7M 250M 289.1M 220.6M 279.8M 471.2M 456.8M 194.5M